|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang M, Yuan F, Li P, Chen Z, Chen A, Li S
and Hu C: Interferon regulatory factor 4 binding protein is a novel
p53 target gene and suppresses cisplatin-induced apoptosis of
breast cancer cells. Mol Cancer. 13:11–54. 2012.
|
|
3
|
Noh EM, Park YJ, Kim JM, Kim MS, Kim HR,
Song HK, Hong OY, So HS, Yang SH, Kim JS, et al: Fisetin regulates
TPA-induced breast cell invasion by suppressing matrix
metal-loproteinase-9 activation via the PKC/ROS/MAPK pathways. Eur
J Pharmacol. 764:79–86. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cui YF, Liu AH, An DZ, Sun RB, Shi Y, Shi
YX, Shi M, Zhang Q, Wang LL, Feng Q, et al: Claudin-4 is required
for vasculogenic mimicry formation in human breast cancer cells.
Oncotarget. 6:11087–11097. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McCracken MN, Cha AC and Weissman IL:
Molecular pathways: Activating T cells after cancer cell
phagocytosis from blockade of CD47 'don't eat me' signals. Clin
Cancer Res. 21:3597–3601. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Frixen UH, Behrens J, Sachs M, Eberle G,
Voss B, Warda A, Löchner D and Birchmeier W: E-cadherin-mediated
cell-cell adhesion prevents invasiveness of human carcinoma cells.
J Cell Biol. 113:173–185. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kohm AP and Miller SD: Role of ICAM-1 and
P-selectin expression in the development and effector function of
CD4+ CD25+ regulatory T cells. J Autoimmun.
21:261–271. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Preca BT, Bajdak K, Mock K, Sundararajan
V, Pfannstiel J, Maurer J, Wellner U, Hopt UT, Brummer T, Brabletz
S, et al: A self-enforcing CD44s/ZeB1 feedback loop maintains eMT
and stemness properties in cancer cells. Int J Cancer. Jun
16–2015.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Weigelt B, Peterse JL and van 't veer LJ:
Breast cancer metastasis: Markers and models. Nat Rev Cancer.
5:591–602. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu X, Liu Q, Fan Y, Wang S, Liu X, Zhu L,
Liu M and Tang H: Downregulation of PPP2R5E expression by miR-23a
suppresses apoptosis to facilitate the growth of gastric cancer
cells. FEBS Lett. 588:3160–3169. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tian X, Wei Z, Wang J, Liu P, Qin Y and
Zhong M: MicroRNA-429 inhibits the migration and invasion of colon
cancer cells by targeting PAK6/cofilin signaling. Oncol Rep.
34:707–714. 2015.PubMed/NCBI
|
|
14
|
Zhang AX, Lu FQ, Yang YP, Ren XY, Li ZF
and Zhang W: MicroRNA-217 overexpression induces drug resistance
and invasion of breast cancer cells by targeting PTEN signaling.
Cell Biol Int. Jun 24–2015.Epub ahead of print. View Article : Google Scholar
|
|
15
|
Lu K, Wang J, Song Y, Zhao S, Liu H, Tang
D, Pan B, Zhao H and Zhang Q: miRNA-24-3p promotes cell
proliferation and inhibits apoptosis in human breast cancer by
targeting p27 Kip1. Oncol Rep. 34:995–1002. 2015.PubMed/NCBI
|
|
16
|
Yamashita D, Kondo T, Ohue S, Takahashi H,
Ishikawa M, Matoba R, Suehiro S, Kohno S, Harada H, Tanaka J, et
al: miR340 suppresses the stem-like cell function of
glioma-initiating cells by targeting tissue plasminogen activator.
Cancer Res. 75:1123–1133. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fernandez S, Risolino M, Mandia N, Talotta
F, Soini Y, Incoronato M, Condorelli G, Banfi S and Verde P:
miR-340 inhibits tumor cell proliferation and induces apoptosis by
targeting multiple negative regulators of p27 in non-small cell
lung cancer. Oncogene. 34:3240–3250. 2015. View Article : Google Scholar
|
|
18
|
Schoumacher M, Goldman RD, Louvard D and
Vignjevic DM: Actin, microtubules, and vimentin intermediate
filaments cooperate for elongation of invadopodia. J Cell Biol.
189:541–556. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gerhardt H, Golding M, Fruttiger M,
Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C,
Alitalo K, Shima D, et al: VEGF guides angiogenic sprouting
utilizing endothelial tip cell filopodia. J Cell Biol.
161:1163–1177. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Klein CA: Cancer. The metastasis cascade.
Science. 321:1785–1787. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nicoloso MS, Spizzo R, Shimizu M, Rossi S
and Calin GA: MicroRNAs - the micro steering wheel of tumour
metastases. Nat Rev Cancer. 9:293–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang H, Fang F, Chang R and Yang L:
MicroRNA-140-5p suppresses tumor growth and metastasis by targeting
transforming growth factor β receptor 1 and fibroblast growth
factor 9 in hepatocellular carcinoma. Hepatology. 58:205–217. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kato M, Goto Y, Matsushita R, Kurozumi A,
Fukumoto I, Nishikawa R, Sakamoto S, Enokida H, Nakagawa M,
Ichikawa T, et al: MicroRNA-26a/b directly regulate La-related
protein 1 and inhibit cancer cell invasion in prostate cancer. Int
J Oncol. 47:710–718. 2015.PubMed/NCBI
|
|
24
|
Wu H, Zhu S and Mo YY: Suppression of cell
growth and invasion by miR-205 in breast cancer. Cell Res.
19:439–448. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hurst DR, Edmonds MD, Scott GK, Benz CC,
Vaidya KS and Welch DR: Breast cancer metastasis suppressor 1
up-regulates miR-146, which suppresses breast cancer metastasis.
Cancer Res. 69:1279–1283. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou X, Wei M and Wang W: MicroRNA-340
suppresses osteosarcoma tumor growth and metastasis by directly
targeting ROCK1. Biochem Biophys Res Commun. 437:653–658. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Takeyama H, Yamamoto H, Yamashita S, Wu X,
Takahashi H, Nishimura J, Haraguchi N, Miyake Y, Suzuki R, Murata
K, et al: Decreased miR-340 expression in bone marrow is associated
with liver metastasis of colorectal cancer. Mol Cancer Ther.
13:976–985. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Berg JS, Powell BC and Cheney RE: A
millennial myosin census. Mol Biol Cell. 12:780–794. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bohil AB, Robertson BW and Cheney RE:
Myosin-X is a molecular motor that functions in filopodia
formation. Proc Natl Acad Sci USA. 103:12411–12416. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cox D, Berg JS, Cammer M, Chinegwundoh JO,
Dale BM, Cheney RE and Greenberg S: Myosin X is a downstream
effector of PI(3)K during phagocytosis. Nat Cell Biol. 4:469–477.
2002.PubMed/NCBI
|
|
31
|
Yonezawa S, Yoshizaki N, Sano M, Hanai A,
Masaki S, Takizawa T, Kageyama T and Moriyama A: Possible
involvement of myosin-X in intercellular adhesion: Importance of
serial pleckstrin homology regions for intracellular localization.
Dev Growth Differ. 45:175–185. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tacon D, Knight PJ and Peckham M: Imaging
myosin 10 in cells. Biochem Soc Trans. 32:689–693. 2004. View Article : Google Scholar : PubMed/NCBI
|
